Free Trial

Mangoceuticals (MGRX) Competitors

Mangoceuticals logo
$1.69 +0.03 (+1.81%)
As of 03:24 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

MGRX vs. MRAI, CCM, BRTX, BGLC, SSY, ACON, ATIP, DHAC, NIVF, and OTRK

Should you be buying Mangoceuticals stock or one of its competitors? The main competitors of Mangoceuticals include Marpai (MRAI), Concord Medical Services (CCM), Biorestorative Therapies (BRTX), BioNexus Gene Lab (BGLC), SunLink Health Systems (SSY), Aclarion (ACON), ATI Physical Therapy (ATIP), Digital Health Acquisition (DHAC), NewGenIvf Group (NIVF), and Ontrak (OTRK). These companies are all part of the "healthcare" industry.

Mangoceuticals vs. Its Competitors

Marpai (NASDAQ:MRAI) and Mangoceuticals (NASDAQ:MGRX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

Mangoceuticals has lower revenue, but higher earnings than Marpai. Marpai is trading at a lower price-to-earnings ratio than Mangoceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Marpai$34.87M0.66-$28.75M-$0.87-1.53
Mangoceuticals$620K13.47-$8.71M-$3.86-0.42

Marpai has a beta of 4.66, suggesting that its stock price is 366% more volatile than the S&P 500. Comparatively, Mangoceuticals has a beta of 2.42, suggesting that its stock price is 142% more volatile than the S&P 500.

Marpai has a net margin of -85.70% compared to Mangoceuticals' net margin of -2,757.86%. Marpai's return on equity of 0.00% beat Mangoceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Marpai-85.70% N/A -100.23%
Mangoceuticals -2,757.86%-85.01%-78.08%

49.8% of Marpai shares are owned by institutional investors. Comparatively, 56.7% of Mangoceuticals shares are owned by institutional investors. 46.1% of Marpai shares are owned by company insiders. Comparatively, 16.0% of Mangoceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Mangoceuticals had 2 more articles in the media than Marpai. MarketBeat recorded 2 mentions for Mangoceuticals and 0 mentions for Marpai. Marpai's average media sentiment score of 1.05 beat Mangoceuticals' score of -0.76 indicating that Marpai is being referred to more favorably in the media.

Company Overall Sentiment
Marpai Positive
Mangoceuticals Negative

Summary

Marpai beats Mangoceuticals on 7 of the 13 factors compared between the two stocks.

Get Mangoceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MGRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MGRX vs. The Competition

MetricMangoceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$8.35M$2.81B$5.81B$9.75B
Dividend YieldN/A1.66%3.84%4.09%
P/E Ratio-0.4222.8230.8925.96
Price / Sales13.47764.02469.53120.82
Price / CashN/A173.2237.1558.38
Price / Book0.435.849.116.37
Net Income-$8.71M$31.83M$3.26B$265.56M
7 Day Performance-1.52%1.75%1.82%1.79%
1 Month Performance-0.92%4.39%4.81%1.13%
1 Year Performance-97.52%11.43%31.07%21.04%

Mangoceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MGRX
Mangoceuticals
0.4471 of 5 stars
$1.69
+1.8%
N/A-97.4%$8.74M$620K-0.443News Coverage
Short Interest ↑
MRAI
Marpai
N/A$1.45
+2.1%
N/A+206.6%$25.04M$34.87M-0.55150Positive News
Gap Down
CCM
Concord Medical Services
0.5186 of 5 stars
$5.44
+2.3%
N/A-25.8%$23.08M$52.60M0.00970Negative News
BRTX
Biorestorative Therapies
2.5086 of 5 stars
$1.51
-2.3%
N/A-10.6%$12.29M$400K-1.197
BGLC
BioNexus Gene Lab
0.03 of 5 stars
$5.32
flat
N/A+31.9%$9.56M$9.51M0.0030Negative News
Earnings Report
SSY
SunLink Health Systems
2.2141 of 5 stars
$1.12
+16.6%
N/A+37.3%$7.88M$31.09M4.661,376Gap Up
ACON
Aclarion
1.5878 of 5 stars
$7.02
-3.6%
$11,758.50
+167,400.0%
-99.6%$4.24M$50K0.007Gap Down
High Trading Volume
ATIP
ATI Physical Therapy
N/A$0.68
flat
N/A-88.6%$2.98M$741.86M-0.045,600
DHAC
Digital Health Acquisition
N/A$0.81
+3.6%
N/A-55.7%$2.92MN/A0.002,021News Coverage
Gap Up
NIVF
NewGenIvf Group
N/A$1.83
-4.2%
N/A-99.8%$1.65M$5.43M0.00N/APositive News
OTRK
Ontrak
2.1817 of 5 stars
$0.10
-68.8%
$3.00
+2,900.0%
-98.2%$1.35M$10.18M-0.01250Negative News

Related Companies and Tools


This page (NASDAQ:MGRX) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners